Dark Mode
National Health Drug Expenditure Data
Patient Health Records & Digital Health
Tags and Keywords
Trusted By
"No reviews yet"
Free
About
This dataset offers an in-depth look into pharmaceutical drug spending across various nations. It presents key indicators such as pharmaceutical expenditure as a share of total health spending, in US dollars per capita (utilising economy-wide Purchasing Power Parities), and as a share of Gross Domestic Product (GDP). Moreover, it includes the total spending by each country for specific years, which has been calculated by combining per capita spending with population figures. The primary data source is the Organisation for Economic Cooperation and Development (OECD), with supplementary population data from DataHub.
Columns
- LOCATION: This column denotes the country code for which pharmaceutical spending data is recorded. Examples include KOR (Korea) and NOR (Norway), with 36 distinct locations represented.
- TIME: Indicates the year of the recorded spending, spanning from 1970 to 2016.
- PC_HEALTHXP: Shows pharmaceutical spending as a percentage of total health expenditure. Values in this column range from 5.54% to 40.2%.
- PC_GDP: Represents pharmaceutical spending as a percentage of Gross Domestic Product. Figures here vary from 0.21% to 2.8%.
- USD_CAP: Details pharmaceutical spending in US dollars per capita, derived using economy-wide PPPs. The values range from 3.16 USD to 1,160 USD.
- FLAG_CODES: This column contains various flag codes, although a significant portion of entries (94%) are null.
- TOTAL_SPEND: The total pharmaceutical spending by a country, calculated by combining "US dollars per capita" with corresponding "population" data. These values show a wide range, from 6.29 USD to 373,000 USD.
Distribution
The dataset is supplied in a CSV format (specifically,
data_csv.csv) and has a file size of approximately 40.61 kB. It is structured with 7 distinct columns and contains 1036 individual records. The dataset is designed for annual updates.Usage
This dataset is particularly well-suited for:
- Economic analysis concerning healthcare expenditure patterns.
- Policy development relating to public health strategies and pharmaceutical market regulation.
- Academic research focused on cross-country comparisons of health spending.
- Identifying spending trends and disparities in access to medicines.
- Evaluating the economic impact of pharmaceutical policies at a national level.
Coverage
The dataset encompasses data for multiple countries, featuring 36 unique geographical locations. The time period covered extends from 1970 to 2016. It provides financial indicators such as pharmaceutical spending as a share of total health spending, as a share of GDP, and in US dollars per capita for these specific countries.
License
CC0: Public Domain
Who Can Use It
- Health economists and financial analysts for conducting comparative studies.
- Government bodies and policymakers engaged in public health planning.
- Researchers and academics across public health and international development fields.
- Pharmaceutical businesses for market insights and analysis.
- Journalists and non-governmental organisations (NGOs) reporting on global health disparities.
Dataset Name Suggestions
- Global Pharmaceutical Expenditure Overview
- Country-Level Drug Spending Analytics
- OECD Pharmaceutical Spending Indicators
- National Health Drug Expenditure Data
- Worldwide Pharmaceutical Spending Benchmarks
Attributes
Original Data Source: National Health Drug Expenditure Data
QUALITY